Queensland life sciences
directory

KE Select is an Australian based, leading Scientific & Medical Recruitment Partner for organisations within the Life Science, Medical, Clinical, Hospital and Healthcare space. Director Kerry McMahon (BSc Biomedical Science) has over 15 years’ experience carrying out Executive Search, Permanent and Contract based recruitment projects in ANZ and more recently into Asia-Pacific. Kerry and her team, they are passionate about tailoring to every client’s needs. The focus for KE Select is to build and maintain personal long-term relationships.

KJR is a software quality engineering consultancy that provides intelligent, technology-based solutions. They have been in operation since 1997, initially focusing on addressing the Y2K issue and have since become a leader in software quality and assurance. They offer services in software QA, DevSecOps, and data quality & AI assurance. KJR has a team of over 100 specialists across Australia and multiple offices in major cities.

Small molecule cancer therapeutics and recent recipient of Cureator award.

KWM is a leading international law firm headquartered in Asia that helps clients to open doors and unlock opportunities as they look to Asian markets to unleash their full potential. With offices in Sydney, Melbourne, Brisbane, Canberra and Perth, KWM is one of the largest law firms in Australia.

Kings Patent & Trade Marks Attorneys is an independent firm in Brisbane, Australia, owned solely by its attorneys, specialising in providing high-quality patents, trademarks, and designs services to creative individuals and businesses, with a strong focus and expertise in the life sciences field, offering responsive, detail-oriented, and strategic support for long-term success, with an experienced team covering diverse technologies including life sciences, the mechanical arts, and software, and providing protection directly before Australian and New Zealand IP Offices or internationally through a reliable network of trusted advisors.

Kira Biotech is an Australian biotech company focused on developing immunomodulatory compounds to treat immune system disorders. Their lead candidate, KB312, is a selective monoclonal antibody that depletes activated immune cells, aiming to restore immune balance and tolerance. With venture capital funding, Kira Biotech is advancing KB312 through preclinical development and phase 1 clinical trials. The company is led by renowned rheumatologist and immunologist, Dr. Dan Baker, along with a team of drug development experts.

Knight Frank work in partnership with our commercial and residential clients to deliver exceptional results and unlock opportunities, together. They are the world’s largest privately-owned property consultancy, we have the distinct advantage of taking a longer term approach and investing in our client relationships versus being driven by the bottom line.

Laronix has developed Bionic Voice, the world’s first smart wearable electronic voice prosthesis for laryngectomy people (larynx amputees or laryngectomees). Bionic Voice substitutes and regeneratesnthe missing "voice source” for laryngectomees.It is naturally controlled by respiration and has an exceptionally high voice quality. The Voice is generated by a smart algorithm and can be trained in its future generation to reach a voice quality resembling the patient’s own.

Life Sciences Queensland is an Australian peak industry group, working to assist the growth of individual firms and organisations, and build the profile, capacity and capability of the life sciences sector to ensure long-term economic, social and environmental benefits to Queensland. LSQ acts as the key point of contact for the life sciences industry.

LigCoat™ is an innovative product that not only contributes to circular economy, unlike other coatings, LigCoat™ does not need to be separated from paper in the recycling process. It is eco-friendly and has the additional benefit of being a strengthening agent. Our proprietary sustainable bio-based coating enables the creation of a water barrier and overcoming the long-term issue of dealing with disposal of single use plastic. Lignin based waterproof coating (may have medical uses)

Logan Office of Economic Development (LOED) is a division of Logan City Council, with the objective of growing the city’s economy through working with investors, businesses and other stakeholders to promote positive economic outcomes.

LuminaX has accelerated 21 Australian startups with $1.2M in direct capital through our VC partners and mentors network, provided connections to over 200 clinicians and experts, linked 9 startups with access to clinical trials and research projects, and supported raising another $2M post program.

MTPConnect is a not-for-profit organization in Australia that aims to accelerate the growth of the medical technology, biotechnology, and pharmaceutical (MTP) sector. It was established in December 2015 by the Australian Government as an independent organization. MTPConnect focuses on strengthening connections between research and industry to maximize opportunities for scientific and technological breakthroughs, as well as their translation and commercialization. Their key areas of focus include increasing collaboration and commercialization, improving management and workforce skills, enhancing access to global supply chains and international markets, and optimizing the regulatory environment.MTPConnect raises awareness, facilitates collaboration, aggregates knowledge, and jointly funds projects that address sector growth priorities and identified constraints and gaps. They have established key hubs in Adelaide, Perth, and Brisbane, along with their head office in Brighton, Victoria. The MTPConnect Board, led by Hon Jaala Pulford, consists of respected industry leaders.MTPConnect also runs various programs funded by the Medical Research Future Fund (MRFF) and other initiatives, supporting research and development in the MTP sector.

Magnetica is an MRI System Original Equipment Manufacturer (OEM) in the clinical and research MRI markets globally. Bringing together the pedigree of these MRI and NMR sub-system OEMs is a transformational event for Magnetica, and the clinical and research MRI markets Magnetica serves and enables.

Mater Research is a recognised leader in medical research. Mater Research works across Mater Health’s hospitals and health services, the University of Queensland, and the world- class Translational Research Institute.

McCullough Robertson is a leading Australian law firm, operating across multiple offices. With a history spanning over 95 years, they have gained the trust of major corporations, financial institutions, governments, and high net worth individuals. Their expertise extends to various industries, including mining, energy, food, real estate, technology, healthcare, and government. McCullough Robertson prioritizes building long-term relationships with their extensive client base, offering reliable advice for their most critical challenges.

The MRCF Collaboration, established and managed by Brandon Capital Partners, provides seed and venture capital investment to support the development and growth of Australian and New Zealand life science companies. The MRCF is a unique collaboration between major Australian superannuation funds, over 50 leading medical research institutes and research hospitals in Australia and New Zealand and CSL. The MRCF supports the development and commercialisation of biomedical discoveries originating from these member research organisations, providing both capital and expertise to guide the successful development of new therapies. Current MRCF funds are the MRCF3 ($200 million) and the MRCF-BTF ($230 million). The MRCF is supported by the Australian and New Zealand governments, as well as the state governments of Victoria, New South Wales, Western Australia, Queensland, South Australia and the Australian Capital Territory

The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

Medicsen has invented a Needle- free Smartpatch for painless delivery of large drugs like insulin, heparin or antibodies using safe ultrasound waves. We have a great team of 16 professionals, a granted patent, a working prototype validated in vivo with 15 pigs and strong interest from the TOP pharma and medtech companies including funding and LOIs.

Melcare is a Life Science company with core competencies in thetherapeutic use of honey. Our products are designed to support and improve treatment outcomes in the areas of eye care, wound and skin care, nasal care and the symptoms of the common cold.

Merck offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services, and digital offerings help create solutions for people globally and a sustainable future for generations to come.

Michael Buck IP is an independent, boutique intellectual property firm, based in Brisbane Australia. We help creative, innovative and inventive people and businesses to protect, defend and commercialise their intellectual assets. Our clients range from local companies and individual inventors to start-ups, international corporations, universities and research organizations.

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.

Microbio is an Australian biotechnology startup that aims to revolutionise pathogen detection with our unique, specific, sensitive and fast pathogen identification test. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology.

Micromune Therapeutics is a startup aiming to develop a small molecule therapeutic for inflammatory bowel disease derived from the microbiome. This builds on research by Mater Research Institute-UQ Associate Professor Jakob Begun and UQ’s Institute for Molecular Bioscience’s Professor Rob Capon.

Midnight Health, a digital health platform to help patients access telehealth consultations, prescriptions, treatments, and other services.

MinterEllison provides legal and consulting services to a diverse client base across industries through offices in Australia and a global network of member firms and associated companies. In Australia, MinterEllison is one of the country's largest law firms.

Morrison Oriental is an Australian-based global business network that supports Australia's supply chain resilience and energy independence through innovation. Our diverse operations span over five countries/markets across the Asia Pacific Region.

information to follow

NeoRehab provides a clinically validated telehealth system for rehabilitation consultations. The eHAB® system allows clinicians like physiotherapists, audiologists, speech pathologists and occupational therapists to provide cost effective services to their patients, regardless of their location. The system was designed by experienced rehabilitation practitioners and offers a simple, intuitive solution for both practitioners and their clients.

Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is now a recognized world leader in the discovery and production of enzymes for molecular biology applications.

Northwest Healthcare Properties Australia is a leading company focused on owning, managing, and developing top-tier hospital, health, and life sciences properties in Australia and New Zealand. With approximately A$6.8 billion in assets under management, they are the largest healthcare real estate owner and developer in the region. Northwest boasts a portfolio of 73 properties with around 270 tenants. They also have a robust development pipeline of approximately A$3.1 billion, with 15 committed projects, 11 of which are currently under construction.

Founded in 2004 and publicly traded since 2010, Northwest (TSX: NWH.UN) is a global real estate investor and asset manager focused on properties and partnerships at the intersection of healthcare, knowledge, and research. We're a real estate investment trust with more than $10B of assets under management, owning and operating a portfolio of more than 230 high-quality properties across Canada, the United States, Brazil, Germany, the Netherlands, the United Kingdom, Australia, and New Zealand.

NuNerve Pty Ltd collaborates with scientists from the University of Queensland to develop a drug candidate for treating motor neurone disease (MND). The drug blocks the EphA4 protein, which plays a crucial role in motor neuron guidance and inhibiting their recovery after injury. This discovery has implications for MND, spinal cord injury, and other neurological diseases, offering a potential treatment for MND patients. NuNerve aims to manufacture the drug for upcoming clinical trials, prioritizing communication through healthcare professionals and providing updates via the QBI website and newsletter. Their urgent goal is to find a cure or disease-modifying strategy for MND.

NuPlant has developed advanced robotic systems for plant tissue-culture. Our SmartClone Sirius and Gemini systems support dissections every three seconds; they unprecedently allow dynamic media change. Our Janus transplanter transfers plantlets to soil and re-assembles consumables for washing in our Neptune system for sustainable re-use. These systems flexibly provide tougher plantlets in shorter time at lower cost.

Nucleus Network's Brisbane facility, formerly known as Q-Pharm, is a dedicated clinical trial unit situated at the Royal Brisbane and Women's Hospital. As Australia's second-largest Phase 1 unit, it conducts clinical trials for companies and researchers involved in developing new, safer, and more effective medications. With over 15 years of reliable experience, Q-Pharm has successfully completed over 400 Early Phase studies and recruited over 15,000 participants. Specializing in early-phase (phases 1 and 2) clinical trials, Q-Pharm operates in a cutting-edge facility located in the Herston precinct at the Royal Brisbane and Women's Hospital in Brisbane, Australia.

OneVentures are one of Australia’s leading venture capital firms, with over $650 million in funds under management and are now looking for new opportunities in the healthcare and technology sectors. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets.

Orthodynamics uses world-first technology to enable orthopaedic surgeons to virtually plan highly personalised surgeries, providing them with 3D printed anatomical models and surgical guides to assist in the operating theatre.

Our Eco Bee’s provisionally-patented technology incorporates revolutionary beekeeping and agricultural eco-system inventions which seek to solve complex ecological, environmental and social problems to ensure: · Beekeepers are profitable and productive · Honey bees are flourishing · Food security is accessible · Agribusiness is sustainable To learn more, please contact Jen Wilks on 61 403 714 006 or via email jen@ourecoclean.com or visit our website.

PEMDx is a medical device company based in Brisbane Australia. A joint collaboration of medical doctors and engineers solving clinical health problems. Their world-first respiratory monitor helps health care staff conduct respiratory assessments. The bag can be fitted to any standard oxygen mask, and it inflates and deflates as a patient breathes.

PEP Health is a communications platform that provides a unique way for patients to monitor, manage and communicate their health journey with their clinical team. Patients use the same tools (clinical surveys, wearables, laboratory test results) their clinicians employ, to monitor and communicate their progress, symptoms and side effects providing their care team with a continuously updated health status snapshot.

PRAXIS Australia is leading national and international education and training provider of high-quality, relevant and accessible training to build the confidence and capability of those working in clinical trials, research and ethics. Their offers have been built upon Harvard Multi-Regional Trials Centre competencies and aligned to NHMRC competencies. These training offers are a benchmark for research and clinical trials professionals in Australia, New Zealand, Asia Pacific Region, Europe, and the United States.

PSC Biotech is a provider of life sciences essential services, ensuring the development, manufacturing, and distribution of medical and biotech products meet regulatory standards. The Australian team specializes in GMP Engineering, offering expertise in commissioning, qualification, and validation (CQV). They assist with validation project planning, documentation generation, execution, and summary reports. Additionally, PSC Biotech offers computer system validation (CSV) and technical writing support for operational readiness. Their focus is on maintaining compliance and delivering high-quality services in the life sciences industry.

Pandemic Advisory & Audit has developed the Sanitary Operational System. This is an innovative device that is scientifically tested, and proven, automated, safe in all spaces, food grade and eco-friendly dry vaporised fog sanitising and deep disinfecting device. The chemical composition has been approved by TGA and FDA as per SDS lodgements.

Parasym is a neurotechnology company focused on providing cutting edge, wearable bioelectric treatment solutions that improve quality of life through targeted modulation of the autonomic nervous system. Parasym's tech has exciting application in cardiovascular disease with RCT results showing improvement in atrial fibrillation burden and QoL in heart failure patients.

Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.

Pfizer is a pharmaceutical company dedicated to making breakthroughs that improve patients' lives and promote global health. They have a long history of innovation and a commitment to social responsibility. Pfizer works with healthcare professionals to gather real-world information for developing treatments, and they strive to make medicines accessible to underserved communities. The company engages in political partnerships in a legal and transparent manner and supports initiatives aligned with their medical and scientific strategies. They invest in research and development, and their executives and scientists lead the way in driving innovation.

PharmaSols is the longest established, best connected, privately-owned Clinical Research Organisation (CRO) in the Pacific region. They have international experience with large pharmaceutical, medical device and biotech organisations, with expertise across a wide variety of therapeutic areas.

Phaslo Global is an environmentally focussed climate tech business that operates in the cold chain logistics industry and specifically within the pathology, aviation and cold freight distribution industries. Phaslo offers environmentally friendly altrenatives to dry ice and polystyrene to temperature control by replacing with a Phase Change Formula.

Pizzey's Patent & Trade Mark Attorney is a specialist intellectual property firm, focusing on patents, trademarks, and designs, with expertise in establishing, maintaining, and enforcing intellectual property rights in Australia, New Zealand, and Singapore, known for its leadership in IP rights protection, driven by qualified attorneys dedicated to upholding the highest standards, offering quality, personalized, and responsive service, and operating as members of the IPH Limited group.

Protagonist Therapeutics is a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.

Provectus Algae is an Australia-based biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.

Q-Sera Pty Ltd uses the coagulant properties of prothrombin activators to create proprietary blood collection tubes that rapidly produce high quality serum. Q-Sera has developed a gold standard serum tube, with a fast turn-around time that can be manufactured for universal implementation.

QBiotics Group is dedicated to improving the lives of people and animals by discovering and creating transformational pharmaceuticals derived from nature. Our primary programmes are in oncology and wound healing.

QHeart Medical was founded by a group of passionate cardiac device professionals focused on serving major unmeet clinical needs. We are currently commercialising a revolutionary low-risk low-cost heart therapy implant for highly unserved hypertensive heart failure and resistant hypertension.

QIMR Berghofer Medical Research Institute is a world- leading translational research institute where research develops from the laboratory bench to the patient’s bedside. With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes.

QUE Oncology is a clinical stage company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122, is focused on the treatment of hot flashes in breast cancer survivors undergoing endocrine therapy.

The aims of the Centre for Genomics and Personalised Health are to translate knowledge from genomics research to improve human health, by discovering better methods of diagnosing disease, developing targeted treatments based on genetics, and training the next generation of translational genomics scientists.

Queensland University of Technology (QUT) is a renowned Australian university that emphasizes a global perspective. With nearly 50,000 students, QUT offers real-world infrastructure, education, and graduate skills to empower the next generation of change-makers. Collaborating with various universities, institutions, and hospitals, QUT is dedicated to research excellence. Their research team is highly regarded for providing government, businesses, and organizations with top-notch research resources. QUT houses cutting-edge facilities and research groups focused on innovative research across various health disciplines. QUT is home to the Centre for Genomics and Personalised Health, contributing to advancements in personalized medicine.

Established in 2003, the Queensland Brain Institute is a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function.

QCIF (the Queensland Cyber Infrastructure Foundation) provides the high-performance services, infrastructure and support required to achieve excellence in computation and data-driven collaborative research and its application in industry. QCIF operates with its members and partners delivering services to research throughout Queensland and increasingly via Commonwealth programs to the nation.

The Queensland Emory Drug Discovery Initiative (QEDDI) is a unique small molecule drug discovery and development group operating within an Australian university, UniQuest. Their mission is to bridge the gap between academic biomedical research and the development of new medicines. With an industry-experienced team, QEDDI focuses on advancing biomedical research into promising drug candidates to facilitate commercial partnerships and expedite drug development. They possess core capabilities and expertise in medicinal chemistry, compound screening, and profiling, enabling them to drive the discovery of innovative therapeutics.

The Queensland Eye Institute is one of the world’s finest centres for eye health, medical research, education and care. It is Queensland’s largest independent academic research institute devoted to eye related health and diseases.

Queensland is fast becoming Australia’s premier investment destination for biomedical and health industry projects. We have a dynamic and diverse economy supported by a pro-business government, sophisticated infrastructure and a skilled workforce.

QIC is a trusted investment manager and adviser providing risk adjusted returns for the clients we serve. As one of Australia’s leading institutional investment managers, we deliver alternative real asset solutions across infrastructure, real estate, private debt, private capital and natural capital in addition to a liquid market offering for our 125 Australian and global clients. We also act as the Queensland Government’s independent investment advisor, managing a fully-funded Defined Benefit scheme and the Queensland Future Fund both of which delivers on the State’s long-term investment objectives. We have US$65bn in assets under management (as at 31 March 2023) and are headquartered in Brisbane, Australia, with offices in Sydney, Melbourne, New York, San Francisco and London.

We are a global drug development accelerator with over 1,300 staff operating from state-of-the-art development, manufacturing and clinical testing facilities in the U.S. and U.K. We have over 30 years of experience and have worked on over 3,000 molecules across all stages of development.

Radium Capital is Australia’s market leader in advances of the R&D Tax Incentive refund. Since launching in 2017, we’ve helped hundreds of innovators build their businesses the strategic way.

Research Collective provides Development, implementation and management of research grant operations; Grants peer review and Change Management services in the health and medical research sector.

Resolian Bioanalytics is a leading global research laboratory providing services for the pharmaceutical, biotechnology, and medical device industries.

Sacco System embodies the fusion of international biotech expertise, catering to the food, nutraceutical, and pharmaceutical industries while supporting food culture and life, with its unique and collaborative network of Caglificio Clerici, Sacco, Centro Sperimentale del latte srl, and Kemikalia, offering a diverse range of innovative products such as starter cultures for food fermentation (especially dairy), nutritional supplements (probiotic cultures), and food enhancement instruments, preserving the distinct qualities and production capabilities of each entity.

Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.

Sartorius is one of the fastest growing global life science companies and a dynamic industry leader. Our ambition is to simplify medical progress from the first idea of a new medication to its production. We support our customers with innovative technologies that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. Around 16,000 employees at over 60 production and sales locations worldwide are committed to this vision.

Savills offers a wide range of property services from investment sales and leasing strategy to valuation, project management, occupier services and asset management across Australia.

Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.

Smilio.ai is a computer vision AI-powered platform that connects patients with dental providers to facilitate virtual consultations, digital oral health check-ups, cosmetic consultations, orthodontic assessments, and treatment monitoring.

We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.

Springfield City Group develops commercial, educational, healthcare, and residential real estate projects, with a vision of making Greater Springfield a sustainable regional city and services hub by 2030. BioPark Australia is to create a place where multiple biologic industries (Therapeutics, Vaccines, Med Tech, Diagnostics will co-locate and grow. Central to the BioPark will be its provision of the complete suite of necessary components and reagents for these industries. Future-proofing is built-in with staged expansion sites available to users.

Recognised for the experience and calibre of its people and high client service standards, Spruson & Ferguson is one of the largest and most trusted intellectual property (IP) service providers in the Asia Pacific region. Our life sciences team in Queensland provide strategic filing advice and services to a wide range of innovators, researchers, universities and businesses. Operating from 10 offices as a regional IP hub, clients can file in over 25 jurisdictions with a single instruction. Offices: Australia, Singapore, China (Beijing & Hong Kong), Indonesia, Malaysia, Philippines, Thailand. Spruson & Ferguson is a member of IPH Limited, an international IP services group comprising a network of member firms working throughout ten IP jurisdictions.

Communities are fundamental. Whether around the corner or across the globe, they provide a foundation, a sense of place and of belonging. That's why at Stantec, we always design with community in mind. We care about the communities we serve—because they're our communities too. This allows us to assess what's needed and connect our expertise, to appreciate nuances and envision what's never been considered, to bring together diverse perspectives so we can collaborate toward a shared success.

Stokes Lawyers is built on the Stokes family legacy of business innovation. We take a mindful and commercial approach to our passion for assisting other family businesses, and private clients, to their opportunity.

Strategic Engineering Australia is a consulting firm that specialises in process engineering, project management and strategic development. From setting up a manufacturing facility to developing and deploying new IT systems, ample experience enables Managing Director Shay Chalmers to intimately understand the entire manufacturing ecosystem.

Stryker R&D Lab officially opened in 2022. In partnership with Queensland Government, the University of Queensland, Queensland University of Technology, and Metro North Health, the Stryker lab will accelerate collaboration to deliver new medical technology innovations and collaboration in advanced manufacturing research.

Sullivan Nicolaides Pathology is one of Australia’s largest and most respected diagnostic testing laboratories, regarded for our expertise in esoteric as much as routine testing. We are a member of the Sonic Healthcare group, a global company with a reputation for excellence.

Sycura Therapeutics is a startup aiming to evaluate a first-in-class brain penetrant small molecule as a preclinical candidate for amyotrophic lateral sclerosis (ALS). This builds on research at UniQuest’s small molecule drug discovery and development group, the Queensland Emory Drug Discovery Initiative (QEDDI) as well as research by Dr Richard Gordon from UQ Centre for Clinical Research.

Therapeutic Innovation Australia (TIA) provides a wide range of translational services. TIA works to lower the bar for researchers to access excellent translational research services in the fields of biologics, cell therapies, small molecules, preclinical testing and clinical trials.

Thermal Armour provides a cure for perioperative hypothermia, the most common serious adverse surgical event in the world.

Thermo Fisher Scientific is a company focused on enabling customers to make the world healthier, cleaner, and safer. They provide products and services in various areas, including genetic testing research, environmental goals, fertility restoration, and community support. The company emphasizes diversity and inclusion and strives to create an environment where differences are valued and everyone feels they belong. Thermo Fisher Scientific also highlights its corporate social responsibility and commitment to making a positive impact on society.

Thomson Geer is a large Australian corporate law firm, delivering services to a wide range of industry sectors and practice areas. Thomson Geer has offices in Sydney, Melbourne, Brisbane and Adelaide. By size, they are one of the 10 largest law firms in Australia.

TickerCardiology, a platform to improve diagnostic cardiology services using cloud-based technology.

Toowoomba and Surat Basin Enterprise (TSBE) is the go-to organisation linking business with opportunity to create sustainable growth and diversity for the region. TSBE is an independent, member-driven economic development organisation actively linking our business community to opportunities across the Toowoomba, Western Downs, Maranoa and surrounding areas.

Trade and Investment Queensland is the Queensland Government’s dedicated global business agency, helping Queensland exporters take their products to world markets and promoting Queensland as the perfect place for investment.

Initially qualified in the Medical Laboratory Sciences, Trevor has been involved in the Healthcare/Biotechnology sector for >30 years in various roles of laboratory, sales, marketing, operational and general management of both multinationals, Australian and self-owned companies.

The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.

The Centre for Advanced Imaging (CAI) within AIBN, is at the forefront of imaging science and is the only centre of its kind in Australia. Bringing together a critical mass of researchers and state-of-the-art preclinical and clinical research infrastructure and instruments, CAI enables world-class research through collaborations with industry and academia while fostering a rich, collaborative environment for our own experts to innovate across spectroscopic and imaging technologies. The CAI’s work is fundamental to a broad range of research fields, from major diseases affecting various organ systems, such as neurodegenerative disorders, cancer, and cardiovascular disease, through to imaging economically significant agricultural animals and plant material, minerals and construction materials. Through techniques such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) spectroscopy, as well as the state-of-the-art isotope production and radiochemistry capability within the centre, our researchers gain unique insights into the structure and function of biomolecules through to whole organisms. CAI’s impact on translational research is maximised through collaboration with clinical research sites and other local, national, and international research institutes. This gives CAI a comprehensive ‘end-to-end’ biomedical imaging capability which allows integrated progression from the laboratory bench, all the way through to a clinical setting.

PEF's vision is to be a world leader in protein research services, technologies and training. PEF has a team of high-performing research specialists providing research capabilities and expertise on recombinant protein production.

Queensland Brain Institute (QBI), home to 250 researchers, all working to unlock the mysteries of the brain to generate new knowledge, understand learning and memory, develop new technologies to improve lives, and diagnose and treat brain disease and mental health. Support our exciting research.

The $70 million UQ Centre for Clinical Research (CCR) at the Royal Brisbane and Women's Hospital (RBWH) is focused on improving people's lives through patient-orientated research. Offer state-of-the-art facilities and bring together leading health professionals, clinicians and scientists from around the globe.